Batch executed with expired SOP during inspection preparation – CAPA ineffectiveness identified


Published on 05/01/2026

Further reading: Manufacturing Deviation Case Studies

Addressing GMP Deviations: The Case of a Batch Executed with Expired SOP During Inspection Preparation

In pharmaceutical manufacturing, maintaining compliance with Good Manufacturing Practices (GMP) is critical to ensuring product quality and safety. This case study discusses a real-world scenario where a batch was executed using an expired Standard Operating Procedure (SOP) while preparing for an inspection. By reviewing this incident, we aim to provide actionable insights on detection, containment, investigation, corrective and preventive actions (CAPA), and the critical lessons learned.

For deeper guidance and related home-care methods, check this Manufacturing Deviation Case Studies.

After reading this article, you will have a structured approach to handling similar deviations, ensuring your facility is inspection-ready while minimizing the risk of recurring non-compliance.

Symptoms/Signals on the Floor or in the Lab

The identification of issues stemming from expired SOPs often begins with various signals noted during the manufacturing process or subsequent quality control checks.

In this case, the symptoms included:

  • Inconsistent product quality: Variations in key performance indicators (KPIs) were observed, including yield and potency results.
  • Deficient documentation: Quality documentation was found to reference outdated SOPs, leading to confusion among personnel.
  • Employee feedback: Operators raised concerns during team meetings that procedures did not align with their daily practices, indicating a disconnect.
  • Increased deviations: An uptick in internal deviations was recorded, particularly focusing on the specific batch manufactured under the expired SOP.

These indicators were taken seriously, triggering an immediate review of the relevant processes and documentation.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

After initial observations of symptoms, it was critical to categorize the probable causes of the expired SOP execution. The investigation categorized these origins as follows:

  • Materials: No direct impact from materials was observed as the batch utilized within specified materials.
  • Method: The execution of the procedure deviated from the intended method due to reliance on an outdated SOP.
  • Machine: No mechanical failures were noted that could inhibit proper execution; however, machine settings were inconsistent with current SOP recommendations.
  • Man: Staff engagement and training deficiencies contributed to procedural adherence issues, leading to execution under an irrelevant SOP.
  • Measurement: There were no measurement-related causes since instruments were calibrated and functioning correctly.
  • Environment: Environmental conditions were verified as being within limits, having no contribution to the SOP issue. However, staff culture was lacking in compliance awareness.
Pharma Tip:  Batch executed with expired SOP during tech transfer – CAPA ineffectiveness identified

This structured categorization facilitated the identification of both direct and indirect influences on the deviation.

Immediate Containment Actions (first 60 minutes)

Once the issue was identified, immediate containment actions were essential to ensure no further batches were executed under outdated procedures. The following steps were promptly taken within the first hour:

  • Cease operations: All manufacturing activities were halted to prevent the execution of any additional batches under the expired SOP.
  • Notify Quality Assurance (QA): The QA team was immediately informed to initiate a review and investigation plan.
  • Secure affected documentation: All references to the expired SOP were removed from the production floor and secured for review.
  • Communicate to staff: An all-hands meeting was convened to inform personnel of the situation and re-emphasize the importance of adhering to current SOPs.
  • Investigation team formation: A cross-functional team was established to investigate and document findings, assigning specific roles to individuals in manufacturing, quality control, and regulatory affairs.

These steps ensured the incident was contained rapidly, reducing the risk of compounding errors or non-compliance events.

Investigation Workflow (data to collect + how to interpret)

The investigation workflow involved several systematic steps to gather data and analyze the incident’s circumstances. Essential data points collected included:

  • Batch records: Transaction records, including equipment logs, materials used, and personnel involved, were reviewed.
  • Training records: Employee training files were evaluated to determine familiarity with current and expired SOPs.
  • Document Control Logs: The evolution of SOP documentation was scrutinized to identify when the previous version expired and any changes in method.
  • Deviation Reports: Historical deviation reports were examined to uncover patterns or recurring issues related to SOP compliance.

The gathered data was interpreted by comparing the deviations against established benchmarks for compliance, ultimately highlighting systematic weaknesses in training and document control processes.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

To identify the root causes of the deviation, several systematic tools were employed:

  • 5-Why Analysis: This method was used during team discussions to drill down into the direct reasons behind the reliance on an expired SOP, leading to personnel training gaps.
  • Fishbone Diagram (Ishikawa): This tool facilitated a visual classification of various non-conformities observed in operator behavior, procedural adherence, and document control lifecycle.
  • Fault Tree Analysis: When looking for broader systemic issues, this method highlighted interdependencies between document control, employee engagement, and training effectiveness.
Pharma Tip:  Process change implemented without QA approval during changeover – CAPA ineffectiveness identified

Each of these tools provided unique insights, ensuring a comprehensive approach to understanding the underlying issues rather than just treating symptoms.

CAPA Strategy (correction, corrective action, preventive action)

Following the identification of root causes, an effective CAPA strategy was laid out to resolve the issues identified. This strategy included:

  • Correction: The executed batch was quarantined and assessed for compliance, ensuring potentially affected products were not released.
  • Corrective Actions:
    • Revising the SOP to include validation measures and a checklist for expiration dates.
    • Re-educating all staff with an emphasis on the importance of using up-to-date documentation.
  • Preventive Actions:
    • Implementing a systematic review process for SOP updates, including automatic notifications for expiration dates.
    • Conducting routine training sessions focusing not only on the content of SOPs but also on the significance of adherence and verification.

These actions will not only address current deficiencies but also fortify systems against future deviations.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

Incorporating a robust control strategy is essential in preventing future occurrences of executing procedures under expired documentation. Recommendations included:

  • Statistical Process Control (SPC): Implementing SPC methods to monitor manufacturing parameters in real time, ensuring compliance with SOPs.
  • Trending and Sampling: Leveraging data analytics to trend batch variations can provide early warnings of quality deviations.
  • Alarms and Alerts: Introducing automated alerts for document revisions or expirations which notify relevant personnel proactively.
  • Verification: Periodically auditing SOP adherence and reinforcing control measures through quality checks will solidify compliance.

Continuous improvement will rely on these proactive measures fostering an environment of compliance and quality assurance.

Validation / Re-qualification / Change Control Impact (when needed)

The investigation indicated that changes in procedures and controls necessitated a review of validation and change control procedures. Key impacts included:

  • Validation: Any updates to manufacturing processes or SOPs related to the incident warranted a validation plan to ensure that new procedures meet all quality standards.
  • Re-qualification: Assessment of affected equipment may have been required to ensure it complies with current SOPs and effectively captures the proposed changes.
  • Change Control: Implementing a formal change control process for documenting updates to SOPs will integrate a level of organizational oversight critical to preventing similar errors.

Regular reviews of validation requirements ensure product quality and encourage adherence to regulations.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

In preparation for inspections—be it by the FDA, EMA, or MHRA—it is necessary to present comprehensive evidence of compliance and investigations uncovered. Essential records to have ready include:

  • Batch Records: Complete records detailing manufacturing history on all affected batches should be thoroughly documented and transparent.
  • Deviation Logs: Robust deviation logs illustrating thorough investigations and corresponding CAPA responses will be critical.
  • Training Records: Ongoing staff training logs must reflect completion rates with targeted training for SOP familiarity.
  • Document Control Logs: Evidence of timely reviews of SOPs and processes will validate compliance efforts.
Pharma Tip:  Critical IPC skipped during changeover – regulatory impact assessment case study

Ensuring these records are easily accessible not only smoothens any inspection process but also reinforces organizational commitment to quality.

FAQs

What should I do if I discover that a batch was executed under an expired SOP?

Immediately halt any further production runs, inform the QA team, and initiate a formal investigation to assess any potential impact on product quality.

How can I prevent future occurrences of expired SOP usage?

Implement systematic reviews of document expiry dates, training sessions for staff, and an alert system for SOP revisions.

What roles should be involved in the CAPA process?

A cross-functional team including representatives from Quality Assurance, Manufacturing, and Regulatory Affairs should be selected to lead CAPA activities.

Related Reads

How often should SOPs be reviewed?

SOPs should be reviewed at least annually or whenever there are changes in processes or regulations impacting the operation.

What should be included in training documentation?

Training records should include participant names, training contents, dates, and assessments confirming understanding of SOP requirements.

How do I ensure inspection readiness post-deviation?

Conduct internal audits, maintain comprehensive and accessible documentation, and ensure all corrective actions from CAPA are implemented effectively.

Are deviations required to be reported to regulatory agencies?

Yes, significant deviations that could impact product quality must be reported, as per the guidelines set forth by regulatory bodies.

What is the best way to approach a 5-Why analysis?

Systematically ask ‘why’ five times for each identified symptom to drill down to the root cause and develop actionable insights.

Conclusion

Deviations in pharmaceutical manufacturing not only affect product quality but also regulatory compliance. The case of the batch executed with an expired SOP underscores the need for effective training, diligent documentation practices, and robust CAPA strategies. By learning from real-world scenarios, pharmaceutical professionals can enhance their manufacturing practices and ensure their processes remain compliance-focused and, therefore, inspection-ready.